Aaron Schuchart
Aaron Schuchart is Chief Business Officer of Lumos Pharma. Mr. Schuchart has over twenty years of experience in key leadership roles for both large multinationals and small biotech companies, including Amgen, Novartis Diagnostics/Grifols, and Coherus Biosciences. Recently, as Chief Business Officer of Aeglea BioTherapeutics, Mr. Schuchart led the Business Development, Commercial Planning, and Intellectual Property...Read More
Chris Bemben
Chris Bemben is Vice President, Business Development of Lumos Pharma. He brings 15 years of business and scientific experience developing novel therapeutics from discovery to late-stage clinical development. As a member of the senior management team, Mr. Bemben collaboratively develops corporate strategy, financial planning, and M&A activity. Prior to joining Lumos, he led business and...Read More
Michael O. Thorner
Michael Thorner is Vice President, Endocrine Sciences of Lumos Pharma. Dr. Thorner most recently was Chair of the Department of Medicine and preceding that was Chief of the Division of Endocrinology and Metabolism and Director of the Clinical Research Center at the University of Virginia. He was responsible for building the Pituitary Program and led...Read More
Aleksandra K. Bruchey
Dr. Bruchey is an academically trained neuroscientist with over 25 years of expertise in development of biopharmaceuticals and devices in the areas of neurology, metabolic diseases, psychiatry, rare diseases, and endocrinology among others, with leadership roles in all facets of therapeutic candidate development from pre-clinical to Phase IV trials. Dr. Bruchey also has broad regulatory...Read More
Roy Smith
Dr. Roy Smith is Scientific Advisor, Endocrine Science of Lumos Pharma. He has more than fifty years of academic and industrial research experience focused on drug discovery with over 300 peer-reviewed publications and issued patents. Upon receiving his Ph.D. in organic chemistry from Queen Mary College, London University, UK., Roy crossed the pond to take...Read More